致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 Human KIR3DL2 Antibody (Lacutamab, Research Use)
目录号 NBR-0057
别名 CD158K; Nkat4a; Nkat4b; NKAT-4; Nkat4
外观 Transparent Liquid
分子量 150kDa
CAS N/A
溶解度 Water, PBS, TBS Buffer,etc.
存储条件 Temp. -80℃
保存时间 see COA
备注1 CHO Expressed
备注2 Ab. Isotype - IgG
目录号 规格 价格 库存状态  
NBR-0057-100UG 100ug ¥550 请咨询
NBR-0057-1MG 1mg ¥3500 请咨询
NBR-0057-5MG 5mg ¥7500 请咨询



【产品概况】
产品名称:Human KIR3DL2 Antibody (Lacutamab, Research Use)
产品编号:NBR-0057
针对靶点:KIR3DL2
抗体药商品名:Lacutamab
抗体药描述:Lacutamab (IPH4102) is a first-in-class anti-KIR3DL2 humanized cytotoxicity-inducing antibody, which is currently in clinical trials for treatment of cutaneous T-cell lymphoma (CTCL), an orphan disease.

【产品参数】
产品外观:Transparent Liquid
分子量:~150kDa
CAS:N/A
溶解度:Water; PBS, TBS Buffer等
表达系统:CHO Expressed
抗体亚型:Ab. Isotype - IgG

 
【基因信息】
Gene Name: KIR3DL2
Synonyms: CD158K; Nkat4a; Nkat4b; NKAT-4; Nkat4
Target Description: KIR3DL2 (Killer Cell Immunoglobulin Like Receptor, Three Ig Domains And Long Cytoplasmic Tail 2) is a Protein Coding gene. Diseases associated with KIR3DL2 include Spondylitis and Mycosis Fungoides. Among its related pathways are Innate Immune System and Class I MHC mediated antigen processing and presentation. An important paralog of this gene is KIR3DL1.
Ensembl: ENSG00000240403
Uniprot: P43630
 
相关产品